Jab delays set back for Priceline sales recovery

MELBOURNE: It will be after Christmas before foot traffic returns in full force ... read more

Dimerix shoots higher on drug study update

SYDNEY: Shares in biotech firm Dimerix opened 6 per cent higher this morning, ... read more

Crescent stays ahead of curve with bid for Healthe Care hospitals

MELBOURNE: Private equity firm Crescent Capital has emerged in the final round of ... read more

Mesoblast braces for class action on drug disclosure

MELBOURNE: A law firm in Australia is preparing a fresh class action claim ... read more